Connect with us

Hi, what are you looking for?

Sunday, Apr 20, 2025
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.
Jay-Z's luxury cannabis line bites the dust 4 years after flashy debut
Jay-Z's luxury cannabis line bites the dust 4 years after flashy debut
Shawn Carter's candy was a bit too overpriced. Photo credit: Monogram

Cannabis

Jay-Z’s luxury cannabis line bites the dust 4 years after flashy debut

People didn’t seem to think that the product was exceptional enough for the exceptionally high price tag

Empire State hip-hop icon Jay-Z attempted to create a successful luxury cannabis line four years ago, but it has been unable to survive in a highly competitive market. Apparently its US$50-dollar joints didn’t live up to consumer expectations.

Monogram was operated by “The Parent Company” before it was acquired by Gold Flora Corp (OTCMKTS: GRAM) last summer. Now, Gold Flora is in the midst of receivership proceedings and is currently ascending down a “debt death spiral,” as described by one knowledgeable source.

Shawn Carter (Jay-Z) served as The Parent Company’s Chief Visionary Officer before the takeover, but his only cannabis leadership role now is at his failing company. Monogram products cannot be found in stock at any of the California and Arizona dispensaries listed on its website.

The Parent Company once had a cash balance exceeding half a billion, but it managed to blow through it and merged into a now-deteriorating cannabis operator.

In an interview with SFGATE this week, renowned cannabis investor and Glass House Brands Inc (OTCMKTS: GLASF) strategic advisor, Seth Yakatan, said that Monogram reviews were generally terrible.

“Monogram was supposed to be an ultra-premium product, and I don’t know anyone who tried it and thought it was anything more than mid-tier,” he said.

Jay’s company tried to market the expensive joints as hand-rolled with the best green available, but his celebrity name and this feature weren’t enough to inspire people to spend half a Benjamin on one reefer cigarette.

Read more: Platform Robotics debuts ‘Softrim’ bud de-leafing gadget at MJBizCon 2024

Read more: New York on track for US$1 billion cannabis sales milestone by year-end

Other celebrity pot brands kick the bucket in recent years

Monogram now joins the ranks of companies that relied on having famous founders for their marketing schemes without the substance and strategy needed to be successful. Tough market conditions are a key factor too.

Flow Kana, associated with comedian and actress Chelsea Handler, is another recent celebrity marijuana failure. It ceased operations in early 2023 due to overwhelming financial issues.

Also Whoopi Goldberg’s medical cannabis company Whoopi & Maya, which shut down in 2020 due to a conflict between Goldberg and co-founder Maya Elisabeth. Like Monogram, this company had an extremely hard time thriving in California’s cutthroat market, another key reason for its disappearance.

 

Follow Mugglehead on X

Like Mugglehead on Facebook

Follow Rowan Dunne on X

rowan@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

CBD

About 98% of participants said it helped alleviate their throbs and aches with little or no side effects

Cannabis

Its construction will cost US$25 million and it will employ up to 100 Kentuckians

AI and Autonomy

They also aim to discover new hemp-derived medicines and genetics through their research

Cannabis

The liquor and cannabis distributor has a strong financial position with C$218.4 million in cash and no debt